Healthcare Brew explores how Angels for Change is addressing the national drug shortage crisis. From our Drug Shortage Hotline—which has helped patients access more than 750,000 medicines since 2022—to efforts that strengthen supply chains and raise awareness, the article highlights the urgent need for solutions and the impact of collaboration across patients, providers, and industry.
A4C Formal Comments on Controlled Substances Forecasting
On August 27, 2025, Angels for Change was featured at the Reagan-Udall Foundation for the FDA’s Public Meeting on Demand Forecasting for Controlled Substances in Washington, DC. Our founder, Laura Bray, was a featured panelist.
In our public comments for the record, we highlighted how outdated and inflexible forecasting processes are leaving patients without access to critical medicines. We called for a more transparent, patient-centered approach that:
Anchors demand forecasting in real-world patient care rather than sales data
Brings together stakeholders across the supply chain, prescribers, and patient advocates
Builds regulatory flexibility to respond to changing patient needs
“We must anchor forecasting in patient care, reimbursement realities, and supply chain insight — not in sales numbers skewed by a constrained, quota-driven market.”
The panel discussion, moderated by Susan Winkler CEO of the Reagan-Udall foundation, brought together leaders from across healthcare to examine the challenges of forecasting controlled substances, the importance of accurate data, and the broader impact on patient access.
Read our full public comments submitted during the meeting below.
Children's Hospital Association features A4C
Angels for Change was featured in the Children’s Hospital Association article, Ensuring Access to Critical Medicines for Children. The piece highlights the ongoing work to address pediatric drug shortages, including how initiatives like Project PROTECT collaborate with manufacturers to prevent disruptions and secure access to critical medicines.
The article shares how shortages of essential treatments—such as electrolytes for NICU babies—can impact care, and why building a more resilient supply chain is essential for children and families nationwide.
2024 Annual Report
Angels for Change Releases 2024 Annual Report
Tampa, FL — Angels for Change has released its 2024 Annual Report, offering a comprehensive look at the organization’s impact over the past year in addressing drug shortages and advancing patient access across the pharmaceutical supply chain.
In a year that saw the highest number of drug shortages ever recorded—323 active shortages reported nationwide—Angels for Change remained committed to collaborative, systems-based solutions. The report outlines measurable progress across advocacy, policy engagement, emergency response, and supply chain resilience.
Key highlights include:
Over 750,000 treatments accessed through our Drug Shortage Hotline and Global Supply Sharing Network
A 98% success rate in addressing patient needs during active shortages
9 essential medicines protected through Project PROTECT
Ongoing leadership on two federal task forces focused on drug shortages
National growth through media coverage, strategic partnerships, and grassroots engagement
As the only nonprofit patient advocacy organization solely focused on ending drug shortages, Angels for Change continues to drive change through cross-sector collaboration, policy leadership, and patient-centered action.
Read the full report to learn more about our 2024 impact and the work ahead.
A4C Statement Featured in Congressional Hearing
Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain
Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”
Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.
Bipartisan MAPS Act Introduced to Congress
New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch
Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care
Change Maker Chronicle: Issue 12, Quarter 2, 2025
The latest edition of The Change Maker Chronicle is here!
We're taking bold steps and sharing real stories as we push the movement to end drug shortages to the NEXT LEVEL.
In this issue, hear directly from Shortage Warriors whose voices are driving change, explore major advocacy milestones, and get a first look at what’s ahead in Q3. From national policy impact to community-powered action, this edition shows what’s possible when Change Makers like you stand with us.
👉 Read the Changemaker Chronicle: Issue 12, Quarter 2, 2025
Together, we’re leveling up the mission—because every patient deserves access to the medicine they need.